- Home
- MHUA vs BMRA Comparison
MHUA vs BMRA Comparison
Compare MHUA & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- BMRA
- Stock Information
- Founded
- MHUA 1990
- BMRA 1971
- Country
- MHUA China
- BMRA United States
- Employees
- MHUA N/A
- BMRA N/A
- Industry
- MHUA Medical Specialities
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MHUA Health Care
- BMRA Health Care
- Exchange
- MHUA Nasdaq
- BMRA Nasdaq
- Market Cap
- MHUA 13.1M
- BMRA 8.5M
- IPO Year
- MHUA 2022
- BMRA N/A
- Fundamental
- Price
- MHUA $0.53
- BMRA $3.39
- Analyst Decision
- MHUA
- BMRA
- Analyst Count
- MHUA 0
- BMRA 0
- Target Price
- MHUA N/A
- BMRA N/A
- AVG Volume (30 Days)
- MHUA 301.1K
- BMRA 27.7K
- Earning Date
- MHUA 04-25-2025
- BMRA 04-14-2025
- Dividend Yield
- MHUA N/A
- BMRA N/A
- EPS Growth
- MHUA N/A
- BMRA N/A
- EPS
- MHUA 0.40
- BMRA N/A
- Revenue
- MHUA $96,909,642.00
- BMRA $5,678,000.00
- Revenue This Year
- MHUA N/A
- BMRA N/A
- Revenue Next Year
- MHUA N/A
- BMRA N/A
- P/E Ratio
- MHUA $1.15
- BMRA N/A
- Revenue Growth
- MHUA N/A
- BMRA 5.01
- 52 Week Low
- MHUA $0.25
- BMRA $1.93
- 52 Week High
- MHUA $1.47
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- MHUA 74.87
- BMRA 46.18
- Support Level
- MHUA $0.38
- BMRA $3.01
- Resistance Level
- MHUA $0.50
- BMRA $3.28
- Average True Range (ATR)
- MHUA 0.05
- BMRA 0.20
- MACD
- MHUA 0.01
- BMRA 0.01
- Stochastic Oscillator
- MHUA 95.92
- BMRA 55.71
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.